Clinical Trial Update: A Study of Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating belimumab for symptomatic Waldenström macroglobulinemia is reported, with no results provided and the trial status listed as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: Cancer Trials Australia | Conditions: Symptomatic Waldenstroms Macroglobulinaemia | Phase 2 | Status: UNKNOWN